mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03612271|
Recruitment Status : Recruiting
First Posted : August 2, 2018
Last Update Posted : November 1, 2019
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Behavioral: mGlide||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||450 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||mGlide RCT: A Clinical Glide Path To Close the Guideline-to-Practice Gap In HTN Management|
|Actual Study Start Date :||March 1, 2019|
|Estimated Primary Completion Date :||December 31, 2022|
|Estimated Study Completion Date :||April 30, 2023|
Experimental: mGlide Intervention
Participants will be educated on HTN and taught to self-monitor their BP. The transmitted BP will be used for adjustment of anti-HTN medications as it occurs in clinical practice.
BP will be automatically transmitted to the providers. The transmitted BP will be used for adjustment of anti-HTN medications as it occurs in clinical practice.
No Intervention: Clinical Care Comparison
Patients will be educated similar to intervention and taught self-monitoring of BP. Then they will be asked to follow up with primary care as usual.
- HTN control into guideline specified range [ Time Frame: 6 months ](SBP <140 mm Hg)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03612271
|Contact: Emily Vollbrechtfirstname.lastname@example.org|
|United States, Minnesota|
|Epidemiology Clinical Research Center||Recruiting|
|Minneapolis, Minnesota, United States, 55415|
|Contact: Emily Vollbrecht|
|Principal Investigator:||Kamakshi Lakshminarayan, MD, PhD||University of Minnesota|